You are here

biotech

Too much success? A booming biotech pipeline will spur intense rivalries — analyst

Too much success? A booming biotech pipeline will spur intense rivalries — analyst

Endpoints

drug development

Flag link:

Nasdaq celebrates record biotech IPO success in 2018. But can the party on Wall Street rumba on?

Nasdaq celebrates record biotech IPO success in 2018. But can the party on Wall Street rumba on?

Endpoints

Flag link:

Could These Be the Next 2 Biotech Buyouts?

Could These Be the Next 2 Biotech Buyouts?

Motley Fool

Agios Pharmaceuticals

Clovis Oncology

Flag link:

Moderna, largest biotech to go public, fails to impress in market debut

Moderna, largest biotech to go public, fails to impress in market debut

Reuters

Moderna Therapeutics

Flag link:

BIO Applauds Inclusion of Pro-Growth Provisions in Tax and Oversight Legislation

BIO Applauds Inclusion of Pro-Growth Provisions in Tax and Oversight Legislation

Businesswire

Flag link:

Can a biotech unicorn break into the record books with a $600M IPO? Stéphane Bancel has a fortune riding on the answer

Can a biotech unicorn break into the record books with a $600M IPO? Stéphane Bancel has a fortune riding on the answer

Endpoints

Stephane Bancel

Flag link:

The flip side of the hot IPO market? A chill could trigger a sudden cash crunch in biotech, followed by more deals

The flip side of the hot IPO market? A chill could trigger a sudden cash crunch in biotech, followed by more deals

Endpoints

Flag link:

In the latest reverse merger, Vienna's Arsanis serves as vehicle for X4 Pharma's Nasdaq listing

In the latest reverse merger, Vienna's Arsanis serves as vehicle for X4 Pharma's Nasdaq listing

Endpoints

Flag link:

Biotech Showcase Conference Reveals Six Therapeutic Areas Receiving the Most Investment Attention in 2019

Biotech Showcase Conference Reveals Six Therapeutic Areas Receiving the Most Investment Attention in 2019

CP Wire

Alzheimer's disease

immuno-oncology

orphan diseases

Flag link:

Chinese foothold in U.S. biotech is growing, USTR report finds

Chinese foothold in U.S. biotech is growing, USTR report finds

BioCentury

Flag link:

California, Massachusetts go toe-to-toe for title of best biotech hub

California, Massachusetts go toe-to-toe for title of best biotech hub

Biopharma Dive

Flag link:

Preclinical biotech Synthorx wants a $100M IPO

Preclinical biotech Synthorx wants a $100M IPO

Fierce Biotech

immuno-oncology

Flag link:

A 29-Year-Old CEO Who's Shaking Up Diagnostics & Other Stories From The 2019 Healthcare 30 Under 30

A 29-Year-Old CEO Who's Shaking Up Diagnostics & Other Stories From The 2019 Healthcare 30 Under 30

Forbes

Flag link:

Moderna aims to raise $500 million in biotech’s largest-ever public offering

Moderna aims to raise $500 million in biotech’s largest-ever public offering

Stat

Moderna Therapeutics

Flag link:

BIO Celebrates 300 Biotech IPOs since Enactment of the JOBS Act

BIO Celebrates 300 Biotech IPOs since Enactment of the JOBS Act

Biotech Now

Flag link:

Biotech's big-bucks buybacks begin to burn

Biotech's big-bucks buybacks begin to burn

EP Vantage

Flag link:

Harvard gets $200M gift to accelerate early-stage R&D

Harvard gets $200M gift to accelerate early-stage R&D

Fierce Biotech

Flag link:

AbbVie hatches plans for a major new R&D hub close to its partners in Bay Area's buzzy Oyster Point

AbbVie hatches plans for a major new R&D hub close to its partners in Bay Area's buzzy Oyster Point

Endpoints

Flag link:

Indicted for biotech insider trading, Rep. Chris Collins keeps his seat

Indicted for biotech insider trading, Rep. Chris Collins keeps his seat

Stat

insider trading

Flag link:

Eli Lilly partner urges investors to look beyond biotech turmoil

Eli Lilly partner urges investors to look beyond biotech turmoil

Indianpolis Business Journal

Innovent Biologics

Flag link:

Pages